Event Schedule

8:00 – 8:50

Bright Start: Registration & Itinerary Collection

8:50 – 9:00

Welcome & Opening Remarks Opening Words

  • Host / Conference Chair
  • Objectives of the Event

Session 1: AI & Digital Transformation in Clinical Trials

9:00 - 9:25

Keynote Presentation: Can AI Truly Transform How Clinical Trials are Designed and Executed

  • How Can AI Improve Trial Feasibility and Site Selection?
  • Can Machine Learning Optimize Monitoring and Risk Prediction?
  • What are the regulatory and Ethical Considerations for AI Use?
9:25 - 9:45

Partner Slot 1: TBC

9:45 - 10:15

Problem Matrix Solution: Barriers to Implementing AI and Digital Tools in Trials

10:15 - 11:15

Coffee Break Networking: Sip, Chat, Connect

Session 2: Modern Trial Designs & Adaptive Methodologies

11:15 - 11:40

Featured Presentation: Can Adaptive Trials Speed Up Development Without Compromising Data Quality

11:40 – 12:05

Partner Slot 2: TBC

12:05 - 12:30

Fireside Chat: Are Platform, Basket, and Umbrella Trials the Future of Precision Medicine

  • How Do These Designs Improve Efficiency Across Multiple Cohorts?
  • What Complexities Do They Introduce for Site Operations?
  • Can They Reduce Patient Exposure to Ineffective Treatments?
12:30 – 13:00

Interactive Panel Discussion & Audience Q&A: How We Operationalize Complex Protocols Seamlessly

  • What Tools Support Risk-based Monitoring in Adaptive Trials?
  • How Do Sites Manage Protocol Amendments Effectively?
  • How Can Sponsors Ensure Alignment Across Global Regions?
13:00 - 14:00

Lunch Break

Session 3: Patient Centricity & Diversity in Clinical Research

14:00 - 14:25

Fireside Chat: How Can We Make Clinical Trials Truly Patient-Centric

  • What Strategies Reduce Patient Burden and Improve Adherence?
  • How Can Feedback Loops Inform Protocol Design?
  • Which Digital Tools Enhance Engagement Without Overwhelming Patients?
14:25 – 14:45

Partner Slot 3: TBC

14:45 – 15:15

Case Study: Are We Reaching the Right Patient Populations

  • How Can We Ensure Diversity and Inclusion in Recruitment?
  • What Barriers Prevent Underrepresented Populations from Participating?
  • Which Community Engagement Strategies Work Best Globally?
15:15 - 16:15

Coffee Break

16:15 – 16:50

Interactive Panel Discussion & Audience Q&A: How Do We Measure Success Beyond Enrollment

  • How Can Patient Experience and Satisfaction be Quantified?
  • What Metrics Track Retention and Long-term Engagement?
  • How Do Patient Outcomes Influence Future Trial Design?
16:50 - 17:00

Closing Remarks & Key Takeaways: Summary of Main Insights

8:00 – 8:50

Bright Start: Registration & Itinerary Collection

8:50 – 9:00

Welcome & Opening Remarks Opening Words

  • Host / Conference Chair
  • Objectives of the event

Session 4: Decentralised, Hybrid & Virtual Trial Models

9:00 - 9:25

Keynote Presentation: Can Decentralized and Hybrid Trials Truly Expand Patient Access

  • How Do Remote Visits and Home-Based Care Improve Participation?
  • What Strategies Ensure Equity and Inclusion Across Populations?
  • How Can Patient Convenience be Balanced with Protocol Integrity?
9:25 - 9:45

Partner Slot 4: TBC

9:45 - 10:15

Panel Discussion: How Do We Maintain Data Quality in Virtual Trial Models

  • Which Technologies Enable Reliable Remote Data Collection?
  • How Can Sites Monitor Compliance Without In-Person Visits?
  • What Metrics Ensure Trial Integrity Across Decentralized Workflows?
10:15 - 11:15

Coffee Break

11:15 - 11:40

Featured Presentation: Are Regulatory Frameworks Ready for Virtual and Hybrid Trials

  • How Do Global Regulations Differ for Decentralized Models?
  • What are the Key Compliance Challenges for Remote Monitoring?
  • How can Sponsors and CROs Standardize Processes Across Regions?

Session 5: Real-World Evidence & External Data Integration

11:40 - 12:05

Deep Dive Presentation: How Can Real-World Evidence Accelerate Clinical Development

  • Which Types of External Data are Most Valuable for Early Decision-making?
  • How Can RWE Complement Traditional Clinical Trial Data?
  • What Challenges Exist in Integrating Diverse Datasets Effectively?
12:05 - 12:30

Fireside Chat: Can External Data Improve Trial Design and Patient Outcomes

  • How Do EHRs, Claims, and Registries Inform Eligibility and Endpoints?
  • What Approaches Ensure Data Quality and Reliability?
  • Can External Controls Reduce the Need for Large Control Arms?
12:30 - 13:00

Stretegic Outlook Panel: What are the Regulatory and Ethical Considerations for RWE Use

  • How Do Regulators View RWE for Submissions and Label Expansion?
  • What Patient Privacy and Consent Issues Must be Addressed?
  • How Do We Standardize Data to Satisfy Multiple Authorities?
13:00 - 14:00

Lunch Break

Session 6: Operational Excellence & CRO Partnerships

14:00 - 14:25

Fireside Chat: How Can Sponsors and CROs Collaborate for Maximum Efficiency

  • What Models Ensure Clear Accountability and Aligned KPIs?
  • How Can Workflows be Streamlined Across Multiple Vendors?
  • What Lessons Can be learneL From Successful Global Partnerships?
14:25 - 14:50

Featured Presentation: Can Operational Excellence Reduce Trial Timelines and Costs

  • Which Process Improvements Have the Highest Impact on Efficiency?
  • How Can Technology Enable Real-time Operational Oversight?
  • What Metrics Best Measure Operational Performance Across Studies?
14:50 - 15:15

Panel Discussion: How Do We Build Resilient, Future-Ready Clinical Teams

  • How Can Cross-functional Alignment Improve Execution?
  • What Training or Tools Ensure Consistency in Complex Trials?
  • How Can Flexibility be Maintained in Adaptive or Decentralized Trials>
15:15 - 16:15

Coffee Break

16:15 - 16:50

Executive Panel Discussion & Audience Q&A: "AI Investment Strategy - Build vs Partner

16:50 - 17:00

Closing Remarks & Key Takeaways: Summary of Main Insights